A phase II study of paclitaxel (P) and carboplatin (C) as second-line treatment in patients (PTS) with small-cell lung cancer (SCLC) von Agelaki, S., Agelidou, M., Blazogiannakis, G., Tsiafaki, X., Palamidas, Th, Kouroussis, Ch, Kakolyris, S., Malliotakis, Ch, Samonis, G., Georgoulias, V.

Volltext

Comparison of docetaxel/cisplatin to docetaxel/gemcitabine as first-line treatment of advanced non-small cell lung cancer: early results of a randomized trial von Georgoulias, V., Samonis, G., Papadakis, E., Alexopoulos, A., Tsiafaki, X., Rapti, A., Veslemes, M., Grigoratou, Th, Palamidas, Ph, Kouroussis, Ch, Mavroudis, D., Kakolyris, S., Giannakakis, Th, Vlachonikolis, J.

Volltext

Second-line treatment of non-small cell lung carcinomas with vinorelbine and ifosfamide: preliminary results of a phase II trial of the Greek Cooperative Group for Lung Cancer von Papadakis, E, Kourousis, Ch, Androulakis, N, Agelaki, S, Apostolopoulou, F, Palamidas, F, Rapti, A, Sarra, E, Tziani, V, Bania, E, Agelidou, A, Gianakakis, Th, Kandilis, K, Adravanis, A, Apostolaki, F, Georgoulias, V

Volltext